abstract |
The human GPC genes have been identified as modulators of the IRRTK or p21 pathway, and thus are therapeutic targets for diseases associated with defective IRRTK or p21 function. Methods are provided for identifying IRRTK or p21 modulators comprising screening to look for agents that modulate the activity of GPC. |